CENTURY THERAPEUTICS INC
IPSCNASDAQ🏆 #3374 by market capEarnings Nov 5 · PreUS Equity
$1.50▲ $0.05 (+3.45%)
Market closed · at closeTrack IPSC
Get earnings, price moves & breaking news on Telegram
24h▲ 3.5%
7d▼ 4.8%
14d▲ 0.0%
30d▼ 8.8%
ytd▲ 53.6%
1y▲ 162.1%
🏦Market Cap
$272M
Small Cap
📈Revenue Growth (YoY)
—
📊Gross Margin
—
💵FCF Margin
—
⚖️P/S Ratio
2.3x
Cheap
Otter Score
—
Insufficient data
CENTURY THERAPEUTICS INC
IPSCAnalyst Ratings
Price
$1.50
Total
9
Raised
0
Lowered
2
Avg PT
$7.50
H / L
$19 / $2
| Institution | Action | Rating | Date | Upside | |
|---|---|---|---|---|---|
HC Wainwright & Co. | Reiterated | Buy | 2026-04-21 | — | — |
Piper Sandler | Reiterated | Overweight | 2026-01-20 | $4.00 | +166.70% |
Leerink Partners | Downgraded | Outperform → Market Perform | 2025-11-17 | $2.00 | +33.30% |
Chardan Capital | Reiterated | Buy | 2025-05-16 | $19.00 | +1166.70% |
Guggenheim | Reiterated | Buy | 2025-03-28 | — | — |
Canaccord Genuity | Reiterated | Buy | 2024-03-15 | — | — |
JP Morgan | Downgraded | Overweight → Neutral | 2023-08-28 | — | — |
EF Hutton | Reiterated | Buy | 2023-08-10 | — | — |
SVB Leerink | Reiterated | Outperform | 2023-01-06 | — | — |
Institution
HC Wainwright & Co.
Reiterated · Buy · 2026-04-21
—
—
Piper Sandler
Reiterated · Overweight · 2026-01-20
$4.00
+166.70%
Leerink Partners
Downgraded · Outperform → Market Perform · 2025-11-17
$2.00
+33.30%
Chardan Capital
Reiterated · Buy · 2025-05-16
$19.00
+1166.70%
Guggenheim
Reiterated · Buy · 2025-03-28
—
—
Canaccord Genuity
Reiterated · Buy · 2024-03-15
—
—
JP Morgan
Downgraded · Overweight → Neutral · 2023-08-28
—
—
EF Hutton
Reiterated · Buy · 2023-08-10
—
—
SVB Leerink
Reiterated · Outperform · 2023-01-06
—
—
One row per institution · price target from the firm's latest published target
StockOtter · stockotter.space